AACR Meeting Abstracts
HOME HELP FEEDBACK HOW TO CITE ABSTRACTS ARCHIVE CME INFORMATION SEARCH
Cancer ResearchClinical Cancer Research
Cancer Epidemiology Biomarkers & PreventionMolecular Cancer Therapeutics
Molecular Cancer ResearchCancer Prevention Research
Cancer Prevention Journals PortalCancer Reviews Online
Annual Meeting Education BookMeeting Abstracts Online
 QUICK SEARCH:   [advanced]




Services
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishi, M.
Right arrow Articles by Ryo, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Nishi, M.
Right arrow Articles by Ryo, A.
[First AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, Sep 12-15, 2006]


Preclinical Studies and Early Drug Development: In Vitro and In Vivo Assays and Models

Role of the prolyl-isomerase Pin1 in cap-dependent translation and cell transformation

Mayuko Nishi, Ichiro Aoki and Akihide Ryo

Yokohama City University School of Medicine, Yokohama, Japan

Abstract

B9

Cap-dependent translation is a fundamental process of gene expression and plays a critical role in cell proliferation and oncogenesis. Cap-dependent translation is initiated by the assembly of the eukaryotic translation initiation factors, eIF4E, eIF4G and eIF4A to form the eIF4F complex, which is often dysregulated in many human malignancies. eIF4E is abnormally highly expressed in multiple human cancers including breast cancer and the overexpression of eIF4E alone can transform mammary epithelial cells. Recent reports also indicate that eIF4E is regulated by specific post-translational modifications such as phosphorylation. However, the subsequent biological effects following phosphorylation have not yet been characterized. We here report that the peptidyl prolyl-isomerase Pin1 regulates eIF4E activation in breast cancer cells. The use of 7-methyl-GTP pull-down analysis reveals that Pin1 is present in eIF4E complexes specifically in breast cancer cells. Pin1 directly binds eIF4E via its Thr9-Pro and Thr11-Pro motifs, and enhances the interaction of both eIF4E and eIF4G with 7-methyl-GTP, thereby facilitating cap-dependent translation. Moreover, the depletion of Pin1 by specific siRNA significantly suppresses eIF4E-mediated cell transformation. These results indicate that Pin1 plays a pivotal role in the inappropriate activation of translational regulation via eIF4E in breast cancer cells, which affects both cell proliferation and oncogenic transformation. Hence, Pin1 could be an intriguing anti-cancer target.







HOME HELP FEEDBACK HOW TO CITE ABSTRACTS ARCHIVE CME INFORMATION SEARCH
Cancer ResearchClinical Cancer Research
Cancer Epidemiology Biomarkers & PreventionMolecular Cancer Therapeutics
Molecular Cancer ResearchCancer Prevention Research
Cancer Prevention Journals PortalCancer Reviews Online
Annual Meeting Education BookMeeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.